abstract |
The present invention relates to methods for the detection of predetermined biomarkers for early diagnosis and management of colorectal tumors, wherein the biomarkers are selected from IL1B, PTGS2, S100A8, LTF, CXCL10, CACNB4, MMP9, CXCL11, EGRI, JUN, TNFSF13B, GATA2, MMPll, NMEl, PTGES, CCRl, CXCR3, FXYD5, IL8, ITGA2, ITGBS, MAPK6, RHOC, BCL3, CD63, CESl, MAP2K3, MSLI, and PPARG. |